The global digital therapeutics market size was estimated at USD 1.7 billion in 2016. A constantly changing digital landscape has grappled the general public and has led to increase in awareness related to personal health and fitness. Furthermore, the burden of chronic diseases is huge and requires effective management. Digital therapeutics offer a wide range of services that propel users to embrace healthy habits and efficiently track and manage their conditions. Digital therapeutics is envisaged to become a significant market segment in the coming years.
U.S. digital therapeutics market, by application, 2014 - 2025 (USD million)
The increasing smartphone and internet usage among the people is one of the significant drivers for digital therapeutic market. For instance, India was ranked 47th for smartphone penetration in 2013 by Google and 36th in 2015. Another significant factor advocating the popularity of digital therapeutics is the cost saving associated with it. Digital therapeutics allow mobile consultations and efficient management of chronic diseases. Chronic diseases are a major threat to the economy and their growth results in high healthcare costs. Statistics published by the CDC in 2012 state that the number of adults suffering from chronic health conditions in the U.S. accounts to about 50% of the total population, highlighting the increasing importance of chronic disease management.
Although the digital therapeutics is a growing market, it is still in its niche phase and is affected by the lack of effective monetization strategies faced by application developers. Currently, advertisements and paid content are the most prominent revenue generating models, but are falling short to meet the financial requirements.
The application segment is divided into diabetes, obesity, cardiovascular diseases, central nervous system disease, respiratory diseases, smoking cessation, and others. Diabetes is expected to record the strongest growth owing to its strong market potential. Diabetes causes significant disease burden and despondence among patients who acquire the disease. According to stats, 8.3% of the population of the U.S. is affected by the disease, with 35% of the U.S. adults exhibiting prediabetes symptoms.
Diabetes is expected to register the fastest growth in the coming years because of its high incidence and prevalence. Patients suffering from diabetes require effective management coaching to handle symptoms like polyuria, polydipsia, and polyphagia. Large number of practitioners are using mhealth and have forecasted that diabetes would reach the highest market potential in the span of next 5 years.
The end use segment is categorized into patients, providers, payers, employers, and others. Patients are the primary users of the therapeutic healthcare applications and programs. Chronically ill people require training and guidance, to take proper care of their health and well-being.
Hospitals are expected to grow at the fastest rate due to increased utilization of digital therapeutic applications to deliver affordable urgent care to patients. By using mobile care facilities, hospitals can help patients browse healthcare services and reduce stress levels.
Canada digital therapeutics market share, by end use, 2016 (USD Million)
The digital therapeutics market by region is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is a major regional segment in digital therapeutic market. Growing number of reforms to curb the increase in healthcare spending in the country coupled with drive to focus on a patient-centric healthcare approach is anticipated to be responsible for the same. Furthermore, North America is a major hub of a large number of digital therapy providers. The U.S. has been reported to spend USD 3 trillion a year on healthcare. In order to curb this expense, there is a dynamic shift in the U.S. healthcare landscape with focus directed toward preventive care, to promote overall patient wellness instead of medical treatment.
Asia Pacific is expected to register fastest growth rate, owing to two major factors: a highly dense population base that converts into a vast target base and rapid urbanization that includes rapidly changing technological landscape. In addition, constant reforms in countries to address lack of proper infrastructure and maintain sustainable growth through financial inclusion is expected to benefit the market.
Some of the key players in this industry include Proteus Digital Health, Inc.; Omada Health, Inc.; WellDoc, Inc.; 2Morrow, Inc.; Livongo Health; Propeller Health; Twine health, Inc.; Canary Health, Inc.; and Mango Health, Inc. Digital therapeutics is currently in a niche stage with homogeneous characteristics. The players are focused on providing optimum customer value on a dynamic level.
However, growth potential is deemed high in the market, which is characterized by an increasing adoption of therapeutic applications by leading providers to facilitate better healthcare provisions. For instance, Barton Health implemented Proteus Discover, marking the first commercial version of the app in the U.S., focusing on uncontrolled and co-morbid hypertension.
Report Attribute |
Details |
Market size value in 2020 |
USD 3,315 million |
Revenue forecast in 2025 |
USD 9.4 billion |
Growth Rate |
CAGR of 21.0% from 2017 to 2025 |
Base year for estimation |
2016 |
Historical data |
2014 - 2016 |
Forecast period |
2017 - 2025 |
Quantitative units |
Revenue in USD million and CAGR from 2017 to 2025 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Application, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
Country scope |
U.S.; Canada; UK; Germany; India; China; Brazil; Mexico; South Africa |
Key companies profiled |
Proteus Digital Health, Inc.; Omada Health, Inc.; WellDoc, Inc.; 2Morrow, Inc.; Livongo Health; Propeller Health; Twine health, Inc.; Canary Health, Inc.; Mango Health, Inc. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at global, regional & country levels and provides an analysis on the latest trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the digital therapeutics market on the basis of application, end use, and region:
Application Outlook (Revenue, USD Million; 2014 - 2025)
Diabetes
Obesity
CVD
CNS Disease
Respiratory Diseases
Smoking Cessation
Others
End use Outlook (Revenue, USD Million; 2014 - 2025)
Patients
Providers
Payers
Employers
Others
Regional Outlook (Revenue, USD Million; 2014 - 2025)
North America
U.S.
Canada
Europe
Germany
UK
Asia Pacific
China
India
Latin America
Brazil
Mexico
MEA
South Africa
b. The global digital therapeutics market size was estimated at USD 2,795.6 million in 2019 and is expected to reach USD 3,315 million in 2020.
b. The global digital therapeutics market is expected to grow at a compound annual growth rate of 19.9% from 2019 to 2025 to reach USD 8,671.5 million by 2025.
b. North America dominated the digital therapeutics market with a share of 41.67% in 2019. This is attributable to growing number of reforms to curb the increase in healthcare spending in the country coupled with drive to focus on a patient-centric healthcare approach.
b. Some key players operating in the digital therapeutics market include Proteus Digital Health, Inc.; Omada Health, Inc.; WellDoc, Inc.; 2Morrow, Inc.; Livongo Health; Propeller Health; Twine health, Inc.; Canary Health, Inc.; and Mango Health, Inc.
b. Key factors that are driving the digital therapeutics market growth include increase in awareness related to personal health and fitness, the burden of chronic diseases coupled with increasing smartphone and internet usage among the people.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."